SCIMEDX is a diagnostic manufacturer with over 30 years of proven experience. Best known for its range of autoimmune and infectious disease testing products. Scimedx extends it's platforms for disease testing. The first was ImmuoCyt+ an FDA cleared & patented assay for bladder cancer. From there Scimedx expanded it's IFA and Latex Infectious assays by acquiring PANBIO for HHV, Dengue, West Nile. Scimedx then went on to acquire Parasitology serology assays from IVD Research. Continuing it's growth, Scimedx has finalized it's rapid testing platform. Scimedx is the de-facto manufacturer of IFA, ELISA, Agglutination tests, delivering solutions for disease testing worldwide.
Looking for a particular Scimedx, Inc employee's phone or email?
The Scimedx, Inc annual revenue was $4 million in 2026.
Fox Britten is the CEO of Scimedx, Inc.
5 people are employed at Scimedx, Inc.
Scimedx, Inc is based in Dover, New Jersey.
The NAICS codes for Scimedx, Inc are [325413, 3254, 32541, 32, 325].
The SIC codes for Scimedx, Inc are [28, 283].